Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.
暂无分享,去创建一个
Andrea Califano | Mariano J. Alvarez | Adam A. Margolin | Katia Basso | Pavel Sumazin | Adam A Margolin | Mariano J Alvarez | Riccardo Dalla-Favera | K. Basso | A. Califano | Pavel Sumazin | A. Margolin | W. Lim | Kai Wang | M. Saito | M. Alvarez | C. Schneider | Y. Kitagawa | Masumichi Saito | Kai Wang | Wei-Keat Lim | Yukiko Kitagawa | Christof Schneider | R. Dalla-Favera
[1] K. Basso,et al. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma , 2009, Proceedings of the National Academy of Sciences.
[2] Kenny Q. Ye,et al. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. , 2009, Blood.
[3] S. V. van Heeringen,et al. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response , 2008, Nucleic acids research.
[4] R. Donnell,et al. Role of Chromodomain Helicase DNA binding protein 2 in DNA damage response signaling and tumorigenesis , 2008, Oncogene.
[5] Andrea Califano,et al. ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes , 2007, Proceedings of the National Academy of Sciences.
[6] A. De Benedetti,et al. Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair. , 2009, DNA repair.
[7] Yanhong Zhang,et al. Syntaxin 6, a Regulator of the Protein Trafficking Machinery and a Target of the p53 Family, Is Required for Cell Adhesion and Survival* , 2008, Journal of Biological Chemistry.
[8] F. Alimirah,et al. Expression of an IFN-Inducible Cellular Senescence Gene, IFI16, Is Up-Regulated by p53 , 2008, Molecular Cancer Research.
[9] M. Cancro,et al. Role of β-Catenin in B Cell Development and Function , 2008, The Journal of Immunology.
[10] A. Melnick,et al. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. , 2008, Blood cells, molecules & diseases.
[11] Hergen Spits,et al. STAT3-Mediated Up-Regulation of BLIMP1 Is Coordinated with BCL6 Down-Regulation to Control Human Plasma Cell Differentiation1 , 2008, The Journal of Immunology.
[12] M. Cancro,et al. Role of beta-catenin in B cell development and function. , 2008, Journal of immunology.
[13] Riccardo Dalla-Favera,et al. Germinal centres: role in B-cell physiology and malignancy , 2008, Nature Reviews Immunology.
[14] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[15] D. Rawlings,et al. B cell–intrinsic TLR signals amplify but are not required for humoral immunity , 2007, The Journal of experimental medicine.
[16] Pier Paolo Di Fiore,et al. Human USP3 Is a Chromatin Modifier Required for S Phase Progression and Genome Stability , 2007, Current Biology.
[17] R. Dalla‐Favera,et al. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells , 2007, Nature Immunology.
[18] T. Kundu,et al. p53 regulates its own activator: transcriptional co-activator PC4, a new p53-responsive gene. , 2007, The Biochemical journal.
[19] K. Basso,et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. , 2007, Cancer cell.
[20] G. Freeman,et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. , 2007, Immunity.
[21] R. Green,et al. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR , 2007, Nature Immunology.
[22] Kenny Q. Ye,et al. Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas , 2007, Proceedings of the National Academy of Sciences.
[23] Michael Q. Zhang,et al. Tissue-specific Regulatory Elements in Mammalian Promoters: Supplementary Information 1 Transcripts and Promoters under Tissue-specific Regulation , 2022 .
[24] D. Frank,et al. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas , 2007, Oncogene.
[25] A. Giaccia,et al. Functional Analysis of p53 Binding under Differential Stresses , 2006, Molecular and Cellular Biology.
[26] Qiong Shen,et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination , 2006, Nature Immunology.
[27] P. Lipsky,et al. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein , 2006, The Journal of experimental medicine.
[28] Chris Wiggins,et al. ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.
[29] Ruslan Medzhitov,et al. Control of B-cell responses by Toll-like receptors , 2005, Nature.
[30] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] K. Basso,et al. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells , 2005, Nature Immunology.
[32] K. Rajewsky,et al. c-Myb is critical for B cell development and maintenance of follicular B cells. , 2005, Immunity.
[33] Qiong Shen,et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. , 2005, Cancer cell.
[34] Adam A. Margolin,et al. Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.
[35] Michael Q. Zhang,et al. Identifying tissue-selective transcription factor binding sites in vertebrate promoters. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] Michael Q. Zhang,et al. Mining ChIP-chip data for transcription factor and cofactor binding sites , 2005, ISMB.
[37] Y. Tu,et al. Cattoretti and Riccardo Dalla-favera Tracking Cd40 Signaling during Germinal Center Development , 2022 .
[38] Ryan T. Phan,et al. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.
[39] David L. Jaye,et al. MTA3 and the Mi-2/NuRD Complex Regulate Cell Fate during B Lymphocyte Differentiation , 2004, Cell.
[40] L. Staudt,et al. Direct Repression of prdm1 by Bcl-6 Inhibits Plasmacytic Differentiation1 , 2004, The Journal of Immunology.
[41] T. Kundu,et al. General Transcriptional Coactivator PC4 Activates p53 Function , 2004, Molecular and Cellular Biology.
[42] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[43] G. Cattoretti,et al. BCL6 Controls the Expression of the B7-1/CD80 Costimulatory Receptor in Germinal Center B Cells , 2003, The Journal of experimental medicine.
[44] Andrea Cocito,et al. Genomic targets of the human c-Myc protein. , 2003, Genes & development.
[45] Katia Basso,et al. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. , 2003, Blood.
[46] Andrea Califano,et al. Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] Alexander E. Kel,et al. TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..
[48] Wei Gu,et al. Acetylation inactivates the transcriptional repressor BCL6 , 2002, Nature Genetics.
[49] S. Elledge,et al. 53BP1, a Mediator of the DNA Damage Checkpoint , 2002, Science.
[50] R. Gascoyne,et al. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma. , 2002, Cancer research.
[51] J. Roes,et al. TGF-β Receptor Controls B Cell Responsiveness and Induction of IgA In Vivo , 2000 .
[52] L. Staudt,et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. , 2000, Immunity.
[53] J. Roes,et al. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. , 2000, Immunity.
[54] V. Bardwell,et al. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT , 1998, Oncogene.
[55] R. Evans,et al. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. , 1998, Nucleic acids research.
[56] L. Pasqualucci,et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Dalla‐Favera,et al. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. , 1998, Genes & development.
[58] U. Storb,et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. , 1998, Science.
[59] S. Iida,et al. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. , 1998, Blood.
[60] D. Leprince,et al. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[61] P. Pandolfi,et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation , 1997, Nature Genetics.
[62] L. Staudt,et al. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. , 1997, Science.
[63] R S Chaganti,et al. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Chaganti,et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. , 1995, The EMBO journal.
[65] K. Offit,et al. BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.
[66] N. Aoki,et al. Recognition DNA sequence of a novel putative transcription factor, BCL6. , 1994, Biochemical and biophysical research communications.
[67] K. Offit,et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. , 1994, Blood.
[68] P. H. Rao,et al. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. , 1993, Cancer research.